GSA Capital Partners’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $618K | Buy |
+186,692
| New | +$618K | 0.04% | 769 |
|
|
2024
Q4 | – | Sell |
-137,151
| Closed | -$683K | – | 1585 |
|
|
2024
Q3 | $683K | Buy |
137,151
+115,223
| +525% | +$574K | 0.05% | 708 |
|
|
2024
Q2 | $57K | Buy |
+21,928
| New | +$57K | ﹤0.01% | 1561 |
|
|
2023
Q4 | – | Sell |
-100,854
| Closed | -$154K | – | 1481 |
|
|
2023
Q3 | $154K | Buy |
100,854
+86,902
| +623% | +$133K | 0.01% | 1333 |
|
|
2023
Q2 | $23K | Buy |
+13,952
| New | +$23K | ﹤0.01% | 1441 |
|
|
2022
Q4 | – | Sell |
-13,704
| Closed | -$16K | – | 1443 |
|
|
2022
Q3 | $16K | Buy |
+13,704
| New | +$16K | ﹤0.01% | 1452 |
|
|
2022
Q2 | – | Sell |
-34,769
| Closed | -$91K | – | 1380 |
|
|
2022
Q1 | $91K | Sell |
34,769
-63,033
| -64% | -$165K | 0.01% | 1304 |
|
|
2021
Q4 | $380K | Sell |
97,802
-199,427
| -67% | -$775K | 0.05% | 775 |
|
|
2021
Q3 | $1.3M | Buy |
297,229
+199,428
| +204% | +$870K | 0.13% | 181 |
|
|
2021
Q2 | $388K | Sell |
97,801
-109,808
| -53% | -$436K | 0.04% | 790 |
|
|
2021
Q1 | $1.08M | Buy |
+207,609
| New | +$1.08M | 0.18% | 120 |
|
|
2019
Q2 | – | Sell |
-11,400
| Closed | -$79K | – | 1423 |
|
|
2019
Q1 | $79K | Buy |
+11,400
| New | +$79K | 0.01% | 1346 |
|